Dr Luke Cox presents at BII Innovation Day as part of Science Prize for Innovation
Dr Luke Cox, CEO of Impulsonics, has attended the BioInnovation Institute (BII) Innovation Day in Copenhagen, Denmark as one of the finalists for the prestigious Science Prize for Innovation.
The event, which took place earlier this week was hosted by BII CTO Markus Herrgård and also included live talks from Holden Thorp, Editor-in-Chief of Science and Mikkel Bülow Skovborg, Senior Vice President at the Novo Nordisk Foundation.
The Science Magazine Team & Innovation Prize finalists & winner.
(Top L-R: Science Editor-in-Chief Holden Thorp, Science Senior Editor Michael Funk, Associate Director of Sales Roger Gonçalve. Bottom L-R: Finalist Dounia Abbadi, finalist Luke Cox, winner Xiaojing Gao)
Photo credit: Esben Zøllner Olesen for BioInnovation Institute (BII)
This event also featured the inaugural presentation of the BII & Science Translational Medicine Prize for Innovation in Women’s Health, which was awarded to Dr. Marlena Fejzo for her pioneering discoveries about severe morning sickness. Her inspiring presentation focused on the path to curing debilitating morning sickness.
Founded in 2017, BII aims to advance research, innovation, and entrepreneurship within the life sciences. Denmark, recognized as the number two innovation leader in the EU, has been at the forefront of attracting investments and collaborating with top tech players globally.
The Science Prize for Innovation recognises bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship.
“Being recognized as a finalist for this award is an incredible honour and meeting the other finalists and winners has served as a huge reminder of just how impactful biotechnology can be on the lives of millions around the world. Being in such esteemed company really validates the hard work and dedication of our team at Impulsonics”
Dr Cox presenting at the BII.
Photo credit: Esben Zøllner Olesen for BioInnovation Institute (BII)
Dr Cox’s prize article, which you can read here, details his journey from University of Bristol student to start-up CEO. Initially working on acoustic levitation of a diamond, he realized the technology's potential to handle small, delicate objects, leading him to work on moving cells.
Impulsonics is developing a biotech automation technology that will enable complex processes to be significantly streamlined, replacing the need for large lab equipment and opening up applications in drug discovery and personalized medicine screening.
Dr Cox expressed his enthusiasm for the event, saying, "BII’s Innovation Day 2025 has been an inspiring fantastic opportunity to connect with other innovators and leaders in the life sciences both in Denmark’s exciting ecosystem and from around the world. I have been excited to share Impulsonics’ journey and learn from the incredible minds present."
Dr Cox's participation in this event highlights his role in advancing scientific innovation and the future of life sciences. "Our work at Impulsonics is driven by a passion for discovery and a commitment to improving lives through technology," Dr. Cox remarked. "I look forward to the collaborations that will emerge from this inspiring event."
About BioInnovation Institute
BioInnovation Institute (BII), accelerates world-class life science start-up innovation to benefit people and society.
Since its inception, BII has awarded 95 million euros to 100 high-growth start-up companies. With their expertise, network, funding, and infrastructure, they empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bii.dk.
About Science/AAAS
The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society and publisher of the journal Science, as well as Science Translational Medicine; Science Signaling; a digital, open-access journal, Science Advances; Science Immunology; and Science Robotics.
About Impulsonics
Impulsonics is a start-up dedicated to making biotech automation simple and scalable so scientists can focus on the problems that matter. Their unique technology leverages acoustic waves to move cells and particles around inside standard labware without touching them, streamlining existing processes and enabling unique new capabilities.
